Background: Studies assessing the prevalence of depression and anxiety in multiple
sclerosis (MS) have used various ascertainment methods that capture different constructs …

Background Within the multiple sclerosis (MS) population, depression and anxiety are highly
prevalent comorbidities that are associated with adverse outcomes such as diminished …

This issue of the International Journal of MS Care (IJMSC) addresses the increasingly
important issue of comorbidity and health behaviors in multiple sclerosis (MS). Many …

Background Individuals with multiple sclerosis (MS) are often plagued by the unpredictability
of their disease and have to contend with uncertainty in their life and significant life changes …

This study examined whether multiple sclerosis (MS) patients (N= 3779) experience change
in their perceived health-related quality of life (HRQOL) over a 5-year period, and …

Background The prevalence of depression in Multiple Sclerosis (MS) is often assessed by
administering patient reported outcome measures (PROMs) examining depressive …

Introduction Studies have found that people with Multiple Sclerosis experience relatively
high rates of anxiety and depression. Although methodologically robust, many of these …

Depression, a common problem in multiple sclerosis (MS), is generally associated with
poorer quality of life (QOL). However, it is unclear whether treating depression also extends …

OBJECTIVE: To validate previous research findings on the prevalence of and factors
associated with depressive symptoms in a community-dwelling sample of individuals with …

Purpose The purposes of this investigation were to (1) identify the domains of health-related
quality of life most impacted in people with RRMS,(2) compare the health-related QOL in …